Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures
Clinical trial NCT01721317 · TERMINATED
Trial details
- NCT number
- NCT01721317
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-19
- Primary completion
- 2013-06-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.